Comment: This 15-year mortality data from ProtecT is a powerful addition to the 12-year patient-reported outcomes (PROs). underscoring the equivalence between the groups in terms of overall survival, but differences in functional outcomes. We already knew from the PROs analysis that generic quality-of-life scores were similar across all three groups (Active Monitoring, Prostatectomy, Radiotherapy) by […]

Read More »

Comment: This analysis  provides critical long-term data and most importantly context for localized prostate cancer treatment decision making. The most striking takeaway is the lack of difference in cancer-specific, or overall survival among the three groups (prostatectomy, radiotherapy, and active monitoring) over the 12-year follow-up. Given that there is no difference in overall survival between […]

Read More »